Optilume Urethral Drug-Coated Balloon
FDA PMAFDA UDIClass III (US FDA PMA)
Identity
- Trade Name
- Optilume Urethral Drug Coated Balloon FDA PMAFDA UDI
- Generic Name
- Catheter, Balloon, Urethral, Drug-Coated FDA PMAUrethral dilatation catheter, drug-eluting FDA UDI
- Device Name
- The Optilume® Urethral Drug Coated Balloon (Optilume DCB) Catheter is a 0.038” (0.97 mm) over-the-wire (OTW) guidewire compatible catheter with a dual lumen design and a tapered, atraumatic tip. The Optilume DCB is used to exert radial force to dilate narrow urethral segments (strictures). The distal end of the catheter has a semi-compliant inflatable balloon that is coated with a proprietary coating containing the active pharmaceutical paclitaxel. The drug coating covers the working length of the balloon body. The device has two radiopaque marker bands that indicate the working length of the balloon where the drug coating is applied. The drug coated balloon is covered with a protective sheath that is discarded prior to use. FDA UDI
- Model / Reference
- 1110 FDA UDI
- Description
- The Optilume® Urethral Drug Coated Balloon (Optilume DCB) Catheter is a 0.038” (0.97 mm) over-the-wire (OTW) guidewire compatible catheter with a dual lumen design and a tapered, atraumatic tip. The Optilume DCB is used to exert radial force to dilate narrow urethral segments (strictures). The distal end of the catheter has a semi-compliant inflatable balloon that is coated with a proprietary coating containing the active pharmaceutical paclitaxel. The drug coating covers the working length of the balloon body. The device has two radiopaque marker bands that indicate the working length of the balloon where the drug coating is applied. The drug coated balloon is covered with a protective sheath that is discarded prior to use. FDA UDI
Identifiers
- Catalog Number
- 1110-10050B FDA UDI
- Primary DI / UDI-DI
- 00853095008310 FDA UDI
- PMA Number
- FDA Product Code
- QRH FDA PMAFDA UDI
- GMDN Term
- Urethral dilatation catheter, drug-eluting FDA UDI
Classification
- Device Class
- Class III FDA PMAFDA UDI
- Advisory Committee
- Gastroenterology, Urology FDA PMA
- FDA Decision
- APPR Approved FDA PMA
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
Single Use
Yes
Implantable
No
Contains Latex
No
Prescription Use
Yes
Over-the-Counter
No
Convenience Kit
No
Combination Product
Yes
HCT/P
No
Premarket Exempt
No
Lot / Batch Number
Yes
Serial Number
No
Expiration Date
Yes
Manufacturing Date
Yes
Dimensions & Sizes
- Size
- Balloon Diameter — 10 Millimeter FDA UDIBalloon Length — 50 Millimeter FDA UDIBalloon Rated Burst Pressure — 10 Atmosphere FDA UDI
The Optilume Urethral Drug-Coated Balloon is a Catheter, Balloon, Urethral, Drug-Coated, classified as a Class III medical device. It is designed to treat obstructive urinary symptoms in adult males caused by anterior urethral strictures up to 3 cm in length by delivering localized drug therapy during dilation.
This device is intended for single-use in urological procedures and requires FDA Premarket Approval (PMA P210020). Sterility, sizing, and MRI safety are not specified in the regulatory submission. It is supplied as a sterile, disposable catheter and must be handled according to standard aseptic techniques prior to use.
Frequently asked questions
What is the Optilume Urethral Drug Coated Balloon used for?
The Optilume Urethral Drug Coated Balloon is designed to treat obstructive urinary symptoms in adult males caused by anterior urethral strictures up to 3 cm in length by delivering localized drug therapy during dilation.
Is the Optilume device reusable or single-use?
The Optilume Urethral Drug Coated Balloon is intended for single-use in urological procedures and must be handled according to standard aseptic techniques prior to use.
What sizes and models of the Optilume device are available?
The device data does not specify available sizes or models for the Optilume Urethral Drug Coated Balloon.
How is the Optilume device supplied?
The Optilume Urethral Drug Coated Balloon is supplied as a sterile, disposable catheter that must be handled according to standard aseptic techniques prior to use.
What is the regulatory status of the Optilume device?
The Optilume Urethral Drug Coated Balloon requires FDA Premarket Approval (PMA P210020) and has been approved for treating obstructive urinary symptoms associated with anterior urethral stricture in adult males.
This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Optilume® for Urethral Stricture | Urethral Drug Coated Balloon, Urotronic - Optilume
Authorization Coverage (1 country)
Regulatory Authorizations
FDA_PMA
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA PMA | United States | FDA_PMA | P210020 | Class III | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Urotronic, Inc.
Sources (2)
- FDA PMA P210020 24 fields · synced Sep 18, 2026
- FDA UDI 3133c732-0297-45ac-a7a8-fe97b6183174 38 fields · synced May 27, 2026